MKC3946
Cat. No.：YN290463
| 产品名称: | MKC3946 |
| CAS No.: | 1093119-54-0 |
| Chemical Name: | 2-hydroxy-6-[5-[(4-methyl-1-piperazinyl)carbonyl]-2-thienyl]-1-naphthalenecarboxaldehyde |
| Synonyms: | MKC3946;MKC-3946;2-hydroxy-6-(5-(4-methylpiperazine-1-carbonyl)thiophen-2-yl)-1-naphthaldehyde;2-hydroxy-6-[5-(4-methylpiperazine-1-carbonyl)thiophen-2-yl]naphthalene-1-carbaldehyde;US8614253, 33-3;BDBM111376;HMS3874H03;BCP20799;s8286;ZB1579;AK683991;2-hy |
| 分子量: | 380.46 |
| 分子式: | C₂₁H₂₀N₂O₃S |
| SMILES: | O=CC1=C(O)C=CC2=C1C=CC(C3=CC=C(C(N4CCN(C)CC4)=O)S3)=C2 |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | MKC3946 是一种有效的IRE1α抑制剂，常用于癌症研究。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Mimura, N., Fulciniti, M., Gorgun, G., et al.Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myelomaBlood119(24),5772-5781(2012)
